The plasmid pET28a-MVHL-STOP2 was amplified by PCR using specific oligonucleotides (forward primer 5′-TCCGGCGTAGAGGATCGAGATC-3′, reverse primer 5′-GACTCGAGCAGATCTATTAAGAGCGGTCGGTAAAACTTCGGCCAGTGAATTTCAGTGGTATTTGTG-3′). The PCR product was transcribed in vitro using T7 RNA polymerase and purified by LiCl/EtOH precipitations. The purified mRNA was capped using Vaccinia Virus Capping Enzyme and the ScriptCap m7G Capping System (CellScript).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.